{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:55:28Z","timestamp":1789152928967,"version":"build-2803163510"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14004-3","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T04:00:40Z","timestamp":1743652840000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["DCE-MRI radiomics of primary breast lesions combined with ipsilateral axillary lymph nodes for predicting efficacy of NAT"],"prefix":"10.1186","volume":"25","author":[{"given":"Yiyao","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxuan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunna","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"issue":"3","key":"14004_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca-Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"Ca-Cancer J Clin"},{"key":"14004_CR2","doi-asserted-by":"crossref","unstructured":"Song DL, Yang F, Zhang YJ, Guo YZ, Qu YW, Zhang XC, Zhu YX, Cui SJ. Dynamic contrast-enhanced MRI radiomics nomogram for predicting axillary lymph node metastasis in breast cancer. Cancer Imaging. 2022;22(1).","DOI":"10.1186\/s40644-022-00450-w"},{"key":"14004_CR3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1093\/annonc\/mds324","volume":"23","author":"AM Thompson","year":"2012","unstructured":"Thompson AM, Moulder-Thompson SL. Neoadjuvant treatment of breast cancer. Ann Oncol. 2012;23:231\u20136.","journal-title":"Ann Oncol"},{"issue":"13","key":"14004_CR4","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1200\/JCO.20.03399","volume":"39","author":"LA Korde","year":"2021","unstructured":"Korde LA, Somerfield MR, Carey LA, Crews JR, Denduluri N, Hwang ES, Khan SA, Loibl S, Morris EA, Perez A, et al. Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for breast cancer: ASCO guideline. J Clin Oncol. 2021;39(13):1485\u2013505.","journal-title":"J Clin Oncol"},{"issue":"5","key":"14004_CR5","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0960-9776(03)00106-1","volume":"12","author":"KN Ogston","year":"2003","unstructured":"Ogston KN, Miller ID, Payne S, Hutcheon AW, Sarkar TK, Smith I, Schofield A, Heys SD. A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival. Breast. 2003;12(5):320\u20137.","journal-title":"Breast"},{"issue":"28","key":"14004_CR6","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.1200\/JCO.2007.10.6823","volume":"25","author":"WF Symmans","year":"2007","unstructured":"Symmans WF, Peintinger F, Hatzis C, Rajan R, Kuerer H, Valero V, Assad L, Poniecka A, Hennessy B, Green M, et al. Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. J Clin Oncol. 2007;25(28):4414\u201322.","journal-title":"J Clin Oncol"},{"issue":"9","key":"14004_CR7","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1001\/jamaoncol.2020.2535","volume":"6","author":"D Yee","year":"2020","unstructured":"Yee D, DeMichele AM, Yau C, Isaacs C, Symmans WF, Albain KS, Chen YY, Krings G, Wei S, Harada S, et al. Association of Event-Free and distant Recurrence-Free survival with Individual-Level pathologic complete response in neoadjuvant treatment of stages 2 and 3 breast cancer Three-Year Follow-up analysis for the I-SPY2 adaptively randomized clinical trial. Jama Oncol. 2020;6(9):1355\u201362.","journal-title":"Jama Oncol"},{"issue":"10175","key":"14004_CR8","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0140-6736(19)30505-7","volume":"393","author":"P Cortazar","year":"2019","unstructured":"Cortazar P, Zhang L, Untch M. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis (384, Pg 164, 2014). Lancet. 2019;393(10175):986\u2013986.","journal-title":"Lancet"},{"key":"14004_CR9","doi-asserted-by":"crossref","unstructured":"Zhang MQ, Du Y, Zha HL, Liu XP, Cai MJ, Chen ZH, Chen R, Wang J, Wang SJ, Zhang JL et al. Construction and validation of a personalized nomogram of ultrasound for pretreatment prediction of breast cancer patients sensitive to neoadjuvant chemotherapy. Brit J Radiol. 2022;95(1140).","DOI":"10.1259\/bjr.20220626"},{"issue":"1","key":"14004_CR10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1245\/s10434-014-3894-0","volume":"22","author":"S Chen","year":"2015","unstructured":"Chen S, Liu Y, Ouyang QW, Huang L, Luo RC, Shao ZM. Clinical and pathological response to neoadjuvant chemotherapy based on primary tumor reduction is correlated to survival in hormone Receptor-Positive but not hormone Receptor-Negative locally advanced breast cancer. Ann Surg Oncol. 2015;22(1):32\u20139.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"14004_CR11","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ejca.2011.11.036","volume":"48","author":"P Lambin","year":"2012","unstructured":"Lambin P, Rios-Velazquez E, Leijenaar R, Carvalho S, van Stiphout RG, Granton P, Zegers CM, Gillies R, Boellard R, Dekker A, et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J cancer (Oxford England: 1990). 2012;48(4):441\u20136.","journal-title":"Eur J cancer (Oxford England: 1990)"},{"issue":"2","key":"14004_CR12","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s10549-018-4990-9","volume":"173","author":"EH Cain","year":"2019","unstructured":"Cain EH, Saha A, Harowicz MR, Marks JR, Marcom PK, Mazurowski MA. Multivariate machine learning models for prediction of pathologic response to neoadjuvant therapy in breast cancer using MRI features: a study using an independent validation set. Breast Cancer Res Tr. 2019;173(2):455\u201363.","journal-title":"Breast Cancer Res Tr"},{"issue":"5","key":"14004_CR13","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/j.acra.2023.11.010","volume":"31","author":"ML Xu","year":"2024","unstructured":"Xu ML, Yang HM, Sun J, Hao HF, Li XJ, Liu GF. Development of an intratumoral and peritumoral radiomics nomogram using digital breast tomosynthesis for preoperative assessment of lymphovascular invasion in invasive breast cancer. Acad Radiol. 2024;31(5):1748\u201361.","journal-title":"Acad Radiol"},{"issue":"4","key":"14004_CR14","doi-asserted-by":"publisher","first-page":"041007","DOI":"10.1117\/1.JMI.2.4.041007","volume":"2","author":"W Guo","year":"2015","unstructured":"Guo W, Li H, Zhu Y, Lan L, Yang S, Drukker K, Morris E, Burnside E, Whitman G, Giger ML, et al. Prediction of clinical phenotypes in invasive breast carcinomas from the integration of radiomics and genomics data. J Med Imaging (Bellingham Wash). 2015;2(4):041007.","journal-title":"J Med Imaging (Bellingham Wash)"},{"issue":"1","key":"14004_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1148\/radiol.14121031","volume":"272","author":"SC Agner","year":"2014","unstructured":"Agner SC, Rosen MA, Englander S, Tomaszewski JE, Feldman MD, Zhang P, Mies C, Schnall MD, Madabhushi A. Computerized image analysis for identifying Triple-Negative breast cancers and differentiating them from other molecular subtypes of breast cancer on dynamic Contrast-enhanced MR images: A feasibility study. Radiology. 2014;272(1):91\u20139.","journal-title":"Radiology"},{"key":"14004_CR16","doi-asserted-by":"crossref","unstructured":"Zhu YT, Li H, Guo WT, Drukker K, Lan L, Giger ML, Ji Y. Deciphering genomic underpinnings of quantitative MRI-based radiomic phenotypes of invasive breast carcinoma. Sci Rep-Uk. 2015;5.","DOI":"10.1038\/srep17787"},{"key":"14004_CR17","doi-asserted-by":"crossref","unstructured":"Fan M, Chen H, You C, Liu L, Gu YJ, Peng WJ, Gao X, Li LH. Radiomics of tumor heterogeneity in longitudinal dynamic Contrast-Enhanced magnetic resonance imaging for predicting response to neoadjuvant chemotherapy in breast cancer. Front Mol Biosci. 2021;8.","DOI":"10.3389\/fmolb.2021.622219"},{"key":"14004_CR18","doi-asserted-by":"crossref","unstructured":"Wang J, Kato F, Oyama-Manabe N, Li RJ, Cui Y, Tha KK, Yamashita H, Kudo K, Shirato H. Identifying Triple-Negative breast cancer using background parenchymal enhancement heterogeneity on dynamic Contrast-Enhanced MRI: A pilot radiomics study. PLoS ONE. 2015;10(11).","DOI":"10.1371\/journal.pone.0143308"},{"issue":"1","key":"14004_CR19","doi-asserted-by":"publisher","first-page":"21691","DOI":"10.1038\/s41598-024-72581-y","volume":"14","author":"H-j Lee","year":"2024","unstructured":"Lee H-j, Lee JH, Lee JE, Na YM, Park MH, Lee JS, Lim HS. Prediction of early clinical response to neoadjuvant chemotherapy in Triple-negative breast cancer: incorporating radiomics through breast MRI. Sci Rep. 2024;14(1):21691.","journal-title":"Sci Rep"},{"key":"14004_CR20","doi-asserted-by":"publisher","first-page":"110247","DOI":"10.1016\/j.ejrad.2022.110247","volume":"150","author":"X Liang","year":"2022","unstructured":"Liang X, Yu X, Gao T. Machine learning with magnetic resonance imaging for prediction of response to neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysis. Eur J Radiol. 2022;150:110247.","journal-title":"Eur J Radiol"},{"issue":"1","key":"14004_CR21","doi-asserted-by":"publisher","first-page":"18800","DOI":"10.1038\/s41598-021-98408-8","volume":"11","author":"S Joo","year":"2021","unstructured":"Joo S, Ko ES, Kwon S, Jeon E, Jung H, Kim J-Y, Chung MJ, Im Y-H. Multimodal deep learning models for the prediction of pathologic response to neoadjuvant chemotherapy in breast cancer. Sci Rep. 2021;11(1):18800.","journal-title":"Sci Rep"},{"issue":"1\u20133","key":"14004_CR22","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1023\/A:1006175504673","volume":"52","author":"N Locopo","year":"1998","unstructured":"Locopo N, Fanelli M, Gasparini G. Clinical significance of angiogenic factors in breast cancer. Breast Cancer Res Treat. 1998;52(1\u20133):159\u201373.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"14004_CR23","doi-asserted-by":"publisher","first-page":"249","DOI":"10.4161\/cam.20567","volume":"6","author":"MW Conklin","year":"2012","unstructured":"Conklin MW, Keely PJ. Why the stroma matters in breast cancer insights into breast cancer patient outcomes through the examination of stromal biomarkers. Cell Adhes Migr. 2012;6(3):249\u201360.","journal-title":"Cell Adhes Migr"},{"issue":"12","key":"14004_CR24","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1177\/1947601911423028","volume":"2","author":"A Christiansen","year":"2011","unstructured":"Christiansen A, Detmar M. Lymphangiogenesis and cancer. Genes cancer. 2011;2(12):1146\u201358.","journal-title":"Genes cancer"},{"issue":"1","key":"14004_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1472-6890-13-31","volume":"13","author":"ZM Mohammed","year":"2013","unstructured":"Mohammed ZM, McMillan DC, Edwards J, Mallon E, Doughty JC, Orange C, Going JJ. The relationship between lymphovascular invasion and angiogenesis, hormone receptors, cell proliferation and survival in patients with primary operable invasive ductal breast cancer. BMC Clin Pathol. 2013;13(1):31.","journal-title":"BMC Clin Pathol"},{"issue":"5","key":"14004_CR26","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.clbc.2015.01.005","volume":"15","author":"A Sanchez-Munoz","year":"2015","unstructured":"Sanchez-Munoz A, Navarro-Perez V, Plata-Fernandez Y, Santonja A, Moreno I, Ribelles N, Alba E. Proliferation determined by Ki-67 defines different pathologic response to neoadjuvant Trastuzumab-Based chemotherapy in HER2-Positive breast cancer. Clin Breast Cancer. 2015;15(5):343\u20137.","journal-title":"Clin Breast Cancer"},{"issue":"8","key":"14004_CR27","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1093\/jnci\/93.8.630","volume":"93","author":"M Greco","year":"2001","unstructured":"Greco M, Crippa F, Agresti R, Seregni E, Gerali A, Giovanazzi R, Micheli A, Asero S, Ferraris C, Gennaro M. Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose\u2013positron emission tomography: clinical evaluation and alternative management. J Natl Cancer Inst. 2001;93(8):630\u20135.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"14004_CR28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/SLA.0b013e318238f461","volume":"255","author":"EA Mittendorf","year":"2012","unstructured":"Mittendorf EA, Hunt KK, Boughey JC, Bassett R, Degnim AC, Harrell R, Yi M, Meric-Bernstam F, Ross MI, Babiera GV. Incorporation of Sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive Sentinel lymph node. Ann Surg. 2012;255(1):109\u201315.","journal-title":"Ann Surg"},{"issue":"Suppl 1Suppl 1","key":"14004_CR29","doi-asserted-by":"publisher","first-page":"S223","DOI":"10.1016\/j.acra.2020.10.015","volume":"29","author":"J Ding","year":"2022","unstructured":"Ding J, Chen S, Serrano Sosa M, Cattell R, Lei L, Sun J, Prasanna P, Liu C, Huang C. Optimizing the peritumoral region size in radiomics analysis for Sentinel lymph node status prediction in breast cancer. Acad Radiol. 2022;29(Suppl 1Suppl 1):S223\u20138.","journal-title":"Acad Radiol"},{"issue":"21","key":"14004_CR30","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","volume":"77","author":"JJM van Griethuysen","year":"2017","unstructured":"van Griethuysen JJM, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V, Beets-Tan RGH, Fillion-Robin JC, Pieper S, Aerts H. Computational radiomics system to Decode the radiographic phenotype. Cancer Res. 2017;77(21):e104\u20137.","journal-title":"Cancer Res"},{"issue":"3","key":"14004_CR31","first-page":"100971","volume":"17","author":"Z Gu","year":"2024","unstructured":"Gu Z, Huang J, Zhou C, Wang Q, Kong J, You X, Zhang Z, Zhao H. Assessing breast cancer volume alterations post-neoadjuvant chemotherapy through DenseNet-201 deep learning analysis on DCE-MRI. J Radiation Res Appl Sci. 2024;17(3):100971.","journal-title":"J Radiation Res Appl Sci"},{"issue":"2","key":"14004_CR32","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15(2):155\u201363.","journal-title":"J Chiropr Med"},{"key":"14004_CR33","first-page":"1341","volume":"10","author":"E Tuv","year":"2009","unstructured":"Tuv E, Borisov A, Runger G, Torkkola K. Feature selection with ensembles, artificial variables, and redundancy elimination. J Mach Learn Res. 2009;10:1341\u201366.","journal-title":"J Mach Learn Res"},{"issue":"1","key":"14004_CR34","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.0006-341X.2001.00120.x","volume":"57","author":"W Pan","year":"2001","unstructured":"Pan W. Akaike\u2019s information criterion in generalized estimating equations. Biometrics. 2001;57(1):120\u20135.","journal-title":"Biometrics"},{"issue":"10","key":"14004_CR35","doi-asserted-by":"publisher","first-page":"4431","DOI":"10.21037\/qims-21-86","volume":"11","author":"C Xue","year":"2021","unstructured":"Xue C, Yuan J, Lo GG, Chang AT, Poon DM, Wong OL, Zhou Y, Chu WC. Radiomics feature reliability assessed by intraclass correlation coefficient: a systematic review. Quant Imaging Med Surg. 2021;11(10):4431.","journal-title":"Quant Imaging Med Surg"},{"issue":"8","key":"14004_CR36","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","volume":"26","author":"A Iasonos","year":"2008","unstructured":"Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26(8):1364\u201370.","journal-title":"J Clin Oncol"},{"issue":"3","key":"14004_CR37","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/bimj.200710415","volume":"50","author":"MD Ruopp","year":"2008","unstructured":"Ruopp MD, Perkins NJ, Whitcomb BW, Schisterman EF. Youden index and optimal cut-point estimated from observations affected by a lower limit of detection. Biometrical J. 2008;50(3):419\u201330.","journal-title":"Biometrical J"},{"issue":"5","key":"14004_CR38","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1002\/bimj.200610223","volume":"48","author":"K Molodianovitch","year":"2006","unstructured":"Molodianovitch K, Faraggi D, Reiser B. Comparing the areas under two correlated ROC curves: parametric and non-parametric approaches. Biometrical J. 2006;48(5):745\u201357.","journal-title":"Biometrical J"},{"issue":"4","key":"14004_CR39","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/bimj.201300058","volume":"56","author":"D Zhang","year":"2014","unstructured":"Zhang D, Zhang B. Semiparametric empirical likelihood confidence intervals for the difference of areas under two correlated ROC curves under density ratio model. Biom J. 2014;56(4):678\u201396.","journal-title":"Biom J"},{"key":"14004_CR40","doi-asserted-by":"publisher","first-page":"980","DOI":"10.3389\/fonc.2019.00980","volume":"9","author":"J Liu","year":"2019","unstructured":"Liu J, Sun D, Chen L, Fang Z, Song W, Guo D, Ni T, Liu C, Feng L, Xia Y, et al. Radiomics analysis of dynamic Contrast-Enhanced magnetic resonance imaging for the prediction of Sentinel lymph node metastasis in breast cancer. Front Oncol. 2019;9:980.","journal-title":"Front Oncol"},{"issue":"5","key":"14004_CR41","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.breast.2012.07.006","volume":"21","author":"ML Marinovich","year":"2012","unstructured":"Marinovich ML, Sardanelli F, Ciatto S, Mamounas E, Brennan M, Macaskill P, Irwig L, von Minckwitz G, Houssami N. Early prediction of pathologic response to neoadjuvant therapy in breast cancer: systematic review of the accuracy of MRI. Breast. 2012;21(5):669\u201377.","journal-title":"Breast"},{"issue":"1","key":"14004_CR42","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1148\/radiol.2281011303","volume":"228","author":"JP Delille","year":"2003","unstructured":"Delille JP, Slaneta PJ, Yeh ED, Halpern EF, Kopans DB, Garrido L. Invasive ductal breast carcinoma response to neoadjuvant chemotherapy: noninvasive monitoring with functional MR imaging - Pilot study. Radiology. 2003;228(1):63\u20139.","journal-title":"Radiology"},{"issue":"Suppl 1","key":"14004_CR43","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1016\/j.acra.2021.12.002","volume":"29","author":"V Romeo","year":"2022","unstructured":"Romeo V. Standardization of quantitative DCE-MRI parameters measurement: an urgent need for breast cancer imaging. Acad Radiol. 2022;29(Suppl 1):S87\u20138.","journal-title":"Acad Radiol"},{"issue":"6","key":"14004_CR44","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.mri.2016.03.001","volume":"34","author":"RF Chang","year":"2016","unstructured":"Chang RF, Chen HH, Chang YC, Huang CS, Chen JH, Lo CM. Quantification of breast tumor heterogeneity for ER status, HER2 status, and TN molecular subtype evaluation on DCE-MRI. Magn Reson Imaging. 2016;34(6):809\u201319.","journal-title":"Magn Reson Imaging"},{"issue":"1","key":"14004_CR45","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00432-021-03822-0","volume":"148","author":"SX Niu","year":"2022","unstructured":"Niu SX, Jiang WY, Zhao NN, Jiang T, Dong Y, Luo YH, Yu T, Jiang XR. Intra- and peritumoral radiomics on assessment of breast cancer molecular subtypes based on mammography and MRI. J Cancer Res Clin. 2022;148(1):97\u2013106.","journal-title":"J Cancer Res Clin"},{"issue":"11","key":"14004_CR46","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1200\/JCO.2014.59.7286","volume":"33","author":"A Oca\u00f1a","year":"2015","unstructured":"Oca\u00f1a A, Diez-G\u00f3nz\u00e1lez L, Adrover E, Fern\u00e1ndez-Aramburo A, Pandiella A, Amir E. Tumor-infiltrating lymphocytes in breast cancer: ready for prime time? J Clin Oncol. 2015;33(11):1298\u20139.","journal-title":"J Clin Oncol"},{"issue":"10","key":"14004_CR47","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1245\/s10434-018-6595-2","volume":"25","author":"N Tamirisa","year":"2018","unstructured":"Tamirisa N, Thomas SM, Fayanju OM, Greenup RA, Rosenberger LH, Hyslop T, Hwang ES, Plichta JK. Axillary nodal evaluation in elderly breast cancer patients: potential effects on treatment decisions and survival. Ann Surg Oncol. 2018;25(10):2890\u20138.","journal-title":"Ann Surg Oncol"},{"key":"14004_CR48","doi-asserted-by":"crossref","unstructured":"Weydandt L, Nel I, Kreklau A, Horn LC, Aktas B. Heterogeneity between core needle biopsy and synchronous axillary lymph node metastases in early breast cancer Patients-A comparison of HER2, Estrogen and progesterone receptor expression profiles during primary treatment regime. Cancers. 2022;14(8).","DOI":"10.3390\/cancers14081863"},{"issue":"11","key":"14004_CR49","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s12094-011-0731-9","volume":"13","author":"V Almendro","year":"2011","unstructured":"Almendro V, Fuster G. Heterogeneity of breast cancer: etiology and clinical relevance. Clin Transl Oncol. 2011;13(11):767\u201373.","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"14004_CR50","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s41467-019-14111-3","volume":"11","author":"F Bras\u00f3-Maristany","year":"2020","unstructured":"Bras\u00f3-Maristany F, Griguolo G, Pascual T, Par\u00e9 L, Nuciforo P, Llombart-Cussac A, Bermejo B, Oliveira M, Morales S, Mart\u00ednez N. Phenotypic changes of HER2-positive breast cancer during and after dual HER2 Blockade. Nat Commun. 2020;11(1):385.","journal-title":"Nat Commun"},{"issue":"3","key":"14004_CR51","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1007\/s00330-021-08293-y","volume":"32","author":"J Gu","year":"2022","unstructured":"Gu J, Tong T, He C, Xu M, Yang X, Tian J, Jiang T, Wang K. Deep learning radiomics of ultrasonography can predict response to neoadjuvant chemotherapy in breast cancer at an early stage of treatment: a prospective study. Eur Radiol. 2022;32(3):2099\u2013109.","journal-title":"Eur Radiol"},{"issue":"6","key":"14004_CR52","doi-asserted-by":"publisher","first-page":"e331","DOI":"10.1016\/j.clbc.2023.05.010","volume":"23","author":"XL Wang","year":"2023","unstructured":"Wang XL, Hua H, Han JQ, Zhong X, Liu JJ, Chen JJ. Evaluation of multiparametric MRI Radiomics-Based nomogram in prediction of response to neoadjuvant chemotherapy in breast cancer: A Two-Center study. Clin Breast Cancer. 2023;23(6):e331\u201344.","journal-title":"Clin Breast Cancer"},{"issue":"2","key":"14004_CR53","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1056\/NEJMoa1406281","volume":"372","author":"SM Tolaney","year":"2015","unstructured":"Tolaney SM, Barry WT, Dang CT, Yardley DA, Moy B, Marcom PK, Albain KS, Rugo HS, Ellis M, Shapira I, et al. Adjuvant Paclitaxel and trastuzumab for Node-Negative, HER2-Positive breast cancer. New Engl J Med. 2015;372(2):134\u201341.","journal-title":"New Engl J Med"},{"key":"14004_CR54","doi-asserted-by":"crossref","unstructured":"Samiei S, Simons JM, Engelen SME, Beets-Tan RGH, Classe JM, Smidt ML, Grp E. Axillary pathologic complete response after neoadjuvant systemic therapy by breast cancer subtype in patients with initially clinically Node-Positive disease A systematic review and Meta-analysis. Jama Surg. 2021;156(6).","DOI":"10.1001\/jamasurg.2021.0891"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14004-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14004-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14004-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T06:04:41Z","timestamp":1743746681000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14004-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14004"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14004-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"assertion":[{"value":"14 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective analysis was approved by the Ethics Committee of Liaoning Cancer Hospital, affiliated with Liaoning Cancer Hospital (Approval No. [20221101]), and the Ethics Committee of the Affiliated Hospital of Qingdao University, affiliated with Qingdao University (Approval No. [QYFY WZLL 28631]), with a waiver of written informed consent from the institutional review board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"589"}}